| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/07/2023 | Wave Life Sciences Ltd. | WVE | Grant | Share Option (right to buy) | 45k | $4.58 | $206.1k | | 08/07/2023 |
| 08/15/2022 | Wave Life Sciences Ltd. | WVE | Grant | Share Option (right to buy) | 21k | $3.50 | $73.5k | | 08/15/2022 |
| 08/16/2021 | Wave Life Sciences Ltd. | WVE | Grant | Share Option (right to buy) | 21k | $5.97 | $125.4k | | 08/16/2021 |
| 08/18/2020 | Wave Life Sciences Ltd. | WVE | Grant | Share Option (right to buy) | 10.5k | $9.13 | $95.9k | | 08/18/2020 |
| 09/04/2019 | Wave Life Sciences Ltd. | WVE | Grant | Share Option (right to buy) | 21k | $21.03 | $441.6k | | 09/04/2019 |
| 02/28/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 454 | $118.61 | $53.8k | | 02/27/2018 |
| 02/27/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 244 | $120.72 | $29.5k | | 02/27/2018 |
| 02/08/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 1.8k | $116.31 | $206.3k | | 02/06/2018 |
| 02/06/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 4.4k | $0.00 | $0 | | 02/06/2018 |
| 02/06/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Grant | Common Stock, par value $.0001 per share | 14.6k | $0.00 | $0 | | 02/06/2018 |
| 02/05/2018 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 655 | $117.26 | $76.8k | | 02/05/2018 |
| 10/03/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 120 | $122.41 | $14.7k | | 10/03/2016 |
| 05/13/2016 | ALEXION PHARMACEUTICALS, INC. | ALXN | Sale | Common Stock, par value $.0001 per share | 53 | $138.65 | $7.3k | | 05/13/2016 |